IL93050D0 - Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents

Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Info

Publication number
IL93050D0
IL93050D0 IL9305090A IL9305090A IL93050D0 IL 93050 D0 IL93050 D0 IL 93050D0 IL 9305090 A IL9305090 A IL 9305090A IL 9305090 A IL9305090 A IL 9305090A IL 93050 D0 IL93050 D0 IL 93050D0
Authority
IL
Israel
Prior art keywords
processes
preparation
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL9305090A
Other versions
IL93050A (en
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB898901423A priority Critical patent/GB8901423D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of IL93050D0 publication Critical patent/IL93050D0/en
Publication of IL93050A publication Critical patent/IL93050A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
IL9305090A 1989-01-23 1990-01-14 2-aryl-3-(heterocyclyl)-pyrazolo-[1,5a]- pyridine derivatives processes for the preparation thereof, and pharmaceutical compositions containing the same IL93050A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB898901423A GB8901423D0 (en) 1989-01-23 1989-01-23 Pyrazolopyridine compound and processes for preparation thereof

Publications (2)

Publication Number Publication Date
IL93050D0 true IL93050D0 (en) 1990-11-05
IL93050A IL93050A (en) 1995-05-26

Family

ID=10650453

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9305090A IL93050A (en) 1989-01-23 1990-01-14 2-aryl-3-(heterocyclyl)-pyrazolo-[1,5a]- pyridine derivatives processes for the preparation thereof, and pharmaceutical compositions containing the same

Country Status (22)

Country Link
US (1) US4985444A (en)
EP (1) EP0379979B1 (en)
JP (2) JPH0794454B2 (en)
KR (1) KR0159502B1 (en)
CN (1) CN1031570C (en)
AT (1) AT150462T (en)
AU (1) AU628913B2 (en)
CA (1) CA2008263C (en)
DE (2) DE69030206D1 (en)
DK (1) DK0379979T3 (en)
ES (1) ES2098229T3 (en)
FI (1) FI96205C (en)
GB (1) GB8901423D0 (en)
GR (1) GR3023219T3 (en)
HU (2) HUT53368A (en)
IE (1) IE900161L (en)
IL (1) IL93050A (en)
NO (1) NO176356C (en)
PH (1) PH30968A (en)
PT (1) PT92935B (en)
RU (1) RU2007403C1 (en)
ZA (1) ZA9000200B (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338743A (en) * 1988-06-06 1994-08-16 Fujisawa Pharmaceutical Co., Ltd. New use of the adenosine antagonist
US5155114A (en) * 1989-01-23 1992-10-13 Fujisawa Pharmaceutical Company, Ltd. Method of treatment using pyrazolopyridine compound
GB9015764D0 (en) * 1990-07-18 1990-09-05 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
GB9107513D0 (en) * 1991-04-10 1991-05-29 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
WO1993025205A1 (en) * 1992-06-10 1993-12-23 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compounds for the treatment of anemia
CA2148502A1 (en) * 1993-09-06 1995-03-16 Fumio Suzuki Antidepressants
AU694157B2 (en) * 1993-12-29 1998-07-16 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine adenosine antagonists
US5646156A (en) * 1994-04-25 1997-07-08 Merck & Co., Inc. Inhibition of eosinophil activation through A3 adenosine receptor antagonism
EP0900796B1 (en) * 1996-04-25 2004-12-15 Fujisawa Pharmaceutical Co., Ltd. Preventives and remedies for ischemic intestinal lesion and ileus
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
WO1998014448A1 (en) * 1996-10-04 1998-04-09 Kyorin Pharmaceutical Co., Ltd. Pyrazolopyridylpyridazinone derivatives and process for the preparation thereof
EP0972525A4 (en) * 1997-03-18 2000-11-29 Fujisawa Pharmaceutical Co Preventives and remedies for hyperphosphatemia
PL194557B1 (en) * 1997-09-05 2007-06-29 Glaxo Group Limited Derivatives of 2,3-diarylpyraxole [1,5-b] pyridazines, their production and application as inhibitors of cyclooxygenase 2(cox-2)
ES2273487T3 (en) * 1998-06-01 2007-05-01 Astellas Pharma Inc. Adenosine A1 antagonists against male sterility.
AUPP672198A0 (en) * 1998-10-23 1998-11-19 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
BR9915011A (en) 1998-11-03 2001-08-07 Glaxo Group Ltd Compounds method for preparing the same, pharmaceutical composition, methods of treating a human or animal subject suffering from a condition which is mediated by selective inhibition of COX-2 and suffering from an inflammatory disorder, and use of a compound
US6541634B2 (en) 1999-02-26 2003-04-01 Pfizer Inc. Process for preparing growth hormone secretagogues
WO2000052008A1 (en) 1999-02-27 2000-09-08 Glaxo Group Limited Pyrazolopyridines
US20040152659A1 (en) * 1999-05-12 2004-08-05 Fujisawa Pharmaceutical Co. Ltd. Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
AUPQ441499A0 (en) * 1999-12-02 2000-01-06 Fujisawa Pharmaceutical Co., Ltd. Novel compound
GB9930358D0 (en) 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
US6756498B2 (en) 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
PE05062002A1 (en) * 2000-08-22 2002-07-09 Glaxo Group Ltd Fused pyrazole derivatives as protein kinase inhibitors
AUPQ969800A0 (en) * 2000-08-28 2000-09-21 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
AU3934402A (en) 2000-12-15 2002-06-24 Glaxo Group Ltd Therapeutic compounds
WO2002048148A2 (en) * 2000-12-15 2002-06-20 Glaxo Group Limited Pyrazolopyridine derivatives
BR0207096A (en) * 2001-02-20 2004-01-20 Astrazeneca Ab Use of a compound, compounds, pharmaceutical formulation and a method of treatment and / or prophylaxis of conditions associated with kinase-3 inhibiting glycogen synthase
EP1366048B1 (en) * 2001-03-08 2004-08-25 SmithKline Beecham Corporation Pyrazolopyridine derivatives
US20050107400A1 (en) * 2001-03-30 2005-05-19 Boyd Leslie F. Use of pyrazolopyridines as therapeutic compounds
EP1372643A1 (en) 2001-03-30 2004-01-02 Smithkline Beecham Corporation Pyrazolopyridines, process for their preparation and use as therapeutic compounds
DE60212949T2 (en) * 2001-04-10 2007-01-04 Smithkline Beecham Corp. Antiviral pyrazolopyridine compounds
DE60204452T2 (en) * 2001-04-27 2005-12-15 Smithkline Beecham Corp. [1,5] pyridine derivatives
AUPR548601A0 (en) * 2001-06-06 2001-06-28 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyrazinecompound and pharmaceutical use thereof
CA2451008A1 (en) * 2001-06-21 2003-01-03 Smithkline Beecham Corporation Imidazo¬1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
WO2003022845A1 (en) * 2001-09-07 2003-03-20 Smithkline Beecham Corporation Pyrazolo-pyridines for the treatment of herpes infections
EP1432712B1 (en) * 2001-10-05 2006-05-17 SmithKline Beecham Corporation Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
AUPR916301A0 (en) * 2001-11-29 2001-12-20 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compound and pharmaceutical use thereof
EP1453830B1 (en) * 2001-12-11 2007-09-12 SmithKline Beecham Corporation Pyrazolo-pyridine derivatives as antiherpes agents
US20040021778A1 (en) * 2002-08-05 2004-02-05 Oldani Jerome L. Security system with remote access and control
GB0218876D0 (en) * 2002-08-13 2002-09-25 Merck Sharp & Dohme Therapeutic agents
US7153863B2 (en) * 2002-10-03 2006-12-26 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridline derivatives
WO2007146087A2 (en) * 2006-06-06 2007-12-21 Avigen, Inc. SUBSTITUTED PYRAZOLO [1,5-α] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE
KR100809368B1 (en) * 2006-08-09 2008-03-05 한국과학기술원 Voice Color Conversion System using Glottal waveform
MX2010011089A (en) 2008-04-15 2010-11-05 Eisai R&D Man Co Ltd 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND.
US20110039873A1 (en) * 2009-06-08 2011-02-17 Gaeta Federico C A SUBSTITUTED PYRAZOLO[1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
EP2487177A1 (en) * 2009-10-08 2012-08-15 Eisai R&D Management Co., Ltd. Pyrazoloxazole compound
AR078521A1 (en) * 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd pirazolotiazol compound
BR112012014858A2 (en) * 2009-12-18 2016-03-29 Mitsubishi Tanabe Pharma Corp antiplatelet agent
MX354175B (en) 2012-04-26 2018-02-16 Squibb Bristol Myers Co Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation.
ES2617879T3 (en) 2012-04-26 2017-06-20 Bristol-Myers Squibb Company Imidazotiadiazol and imidazopyridazine derivatives as inhibitors of the protease-activated receptor 4 (PAR4) for the treatment of platelet aggregation
EA201491967A1 (en) 2012-04-26 2015-03-31 Бристол-Майерс Сквибб Компани Imidazotiadiazola derivatives as inhibitors of the protease-activated receptor 4 (par4) for the treatment of platelet aggregation
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention
TWI629982B (en) * 2013-05-28 2018-07-21 拉夸里亞創藥股份有限公司 Polymorphic forms
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154583A (en) * 1974-11-01 1976-05-13 Kyorin Seiyaku Kk Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
AT381312B (en) * 1982-06-16 1986-09-25 May & Baker Ltd A process for the preparation of the novel N, N-dimethylcarbamoyl-3-pyrazolo (1,5-a) pyridine
FR2601368B1 (en) * 1986-07-08 1989-04-07 Synthelabo Derivatives of nitrofuran, their preparation and their therapeutic application.
JPS63135381A (en) * 1986-11-26 1988-06-07 Japan Found Cancer Res Sensitivity enhancer for multidrug-resistant cancerous cell and production thereof
DE3710937A1 (en) * 1987-04-01 1988-10-13 Boehringer Mannheim Gmbh Chromogenic compounds, their manufacture and use as enzyme substrates
US4925849A (en) * 1987-06-15 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines

Also Published As

Publication number Publication date
GB8901423D0 (en) 1989-03-15
DE69030206D1 (en) 1997-04-24
FI96205C (en) 1996-05-27
AT150462T (en) 1997-04-15
FI900307D0 (en)
ES2098229T3 (en) 1997-05-01
FI900307A0 (en) 1990-01-19
NO900306D0 (en) 1990-01-22
JPH0881465A (en) 1996-03-26
JPH02243689A (en) 1990-09-27
DE69030206T2 (en) 1997-07-10
NO176356C (en) 1995-03-22
HU900228D0 (en) 1990-03-28
PT92935A (en) 1990-07-31
EP0379979A1 (en) 1990-08-01
HU211684A9 (en) 1995-12-28
GR3023219T3 (en) 1997-07-30
CN1044656A (en) 1990-08-15
IE900161L (en) 1990-07-23
CA2008263C (en) 2000-03-14
EP0379979B1 (en) 1997-03-19
JPH0794454B2 (en) 1995-10-11
HUT53368A (en) 1990-10-28
RU2007403C1 (en) 1994-02-15
NO900306L (en) 1990-07-24
DK0379979T3 (en) 1997-04-07
PH30968A (en) 1997-12-23
AU4869690A (en) 1990-07-26
NO176356B (en) 1994-12-12
AU628913B2 (en) 1992-09-24
ZA9000200B (en) 1990-10-31
US4985444A (en) 1991-01-15
CA2008263A1 (en) 1990-07-23
IL93050A (en) 1995-05-26
CN1031570C (en) 1996-04-17
KR0159502B1 (en) 1998-12-01
PT92935B (en) 1995-12-29
FI96205B (en) 1996-02-15

Similar Documents

Publication Publication Date Title
AU631466B2 (en) New 1,2-benzisoxazole derivatives, processes for preparing them and pharmaceutical compositions containing them
SK28093A3 (en) N-phenyl-2-pyrimidinamine derivatives, process for their preparation and their pharmaceutical compositions
NZ234883A (en) Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof
GR3018819T3 (en) Novel arylethylamin derivatives, processes for their preparation and pharmaceutical compositions containing them.
IL86782A (en) Amino acid derivatives, processes for the preparation thereof and pharmaceutical compositions comprising the same
IL91129D0 (en) Aminomethyloxooxazolidinyl arylbenzene derivatives,their preparation and pharmaceutical compositions containing them
NZ245869A (en) Azaindole derivatives, preparation and pharmaceutical compositions thereof
EP0419653A4 (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
IL105729D0 (en) Azepine derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
IL90949D0 (en) Fr901228 substance,processes for the preparation thereof and pharmaceutical compositions containing the same
IL90245D0 (en) Ethenediamine derivatives,their preparation and pharmaceutical compositions containing them
NZ230071A (en) Aminomethyltetralin derivatives, preparation and pharmaceutical compositions thereof
SK97787A3 (en) Indolizine derivatives, process for their preparation and pharmaceutical or verinary composition containing them
IE68857B1 (en) Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same
IL93422D0 (en) Glycine derivatives,their preparation and pharmaceutical compositions containing them
IL93325D0 (en) Isoquinoline derivatives,process for their preparation and pharmaceutical compositions containing them
SK73494A3 (en) Isatin derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
IL95568D0 (en) N-substituted-4-pyrimidinamines and pyrimidinidiamines,process for their preparation and pharmaceutical compositions containing them
IL95118D0 (en) Polypeptide derivatives,their preparation and pharmaceutical compositions containing them
IL80670D0 (en) Bicyclic sulfonamide derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB9307527D0 (en) New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IL99443D0 (en) Heterocyclic derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL95269D0 (en) Diarylacetylenes,their preparation and pharmaceutical compositions containing them
IL95640D0 (en) 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them
IL98526D0 (en) Pyridones,processes for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patents renewed
FF Patents granted
KB Patents renewed
RH1 Patents not in force